Wednesday, August 15, 2018
 
 
Company News: Page (1) of 1 - 07/17/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Medical Marketing and Media Names Arteric an Agency to Watch

(July 17, 2018)

Summit, NJ, July 17, 2018 --(PR.com)-- For 2 decades, Arteric’s pharmaceutical and biotechnology marketing clients have lauded the agency for always being on watch for opportunities that provide brands with competitive advantage. On July 9, Medical Marketing and Media (MM&M) encouraged brand teams and the healthcare marketing industry to do the watching, when it named Arteric to its Ones to Watch list for 2018. The agencies selected as Ones to Watch have been acclaimed for their recent work and are poised to grow in the year ahead.



One of only eight agencies to be honored, inclusion on the MM&M Ones to Watch list is the latest achievement in an award-winning run for Arteric. In 2017 and 2018, Arteric has garnered 8 design and usability awards (to date) from the Communicator Awards Competition, the MobileWebAwards Competition, and the Internet Advertising Competition.



The MM&M honor recognizes Arteric’s thought leadership in healthcare marketing. Arteric president and chief strategist Hans Kaspersetz has shared the agency’s groundbreaking work with artificial intelligence by speaking at venues that include the Digital Pharma and Biopharma eMarketing series of digital marketing conferences and the FutureTech Pharma workshop. Mr. Kaspersetz has also been invited to author industry viewpoints in trade publications PM360 and MM&M.

Larry Dobrow writes for MM&M, “The agency is smart. If you don't come out of a conversation with cofounder Hans Kaspersetz thinking differently about the industry - and in particular its digital evolution - you likely weren't paying attention. Beyond its thought-leadership initiatives, Arteric added several new assignments from Celgene and welcomed Moberg Pharma to a roster that already included Novartis and Daiichi Sankyo.”

“This honor is two decades in the making,” states Mr. Kaspersetz. “We built our organization on a foundation of exceptional software engineering skill; framed it with expertise in healthcare marketing, search engine optimization, and analytics; and extended our capabilities to exploit the ever-changing technology landscape. But the secret sauce has been and always will be the people who work here and the values that we share.”

Mr. Kaspersetz adds these thoughts on the growth of Arteric. “We’re experiencing an acceleration in new opportunities across our spectrum of capabilities. This has led to an expansion in our leadership team and our general capacity. The influx of talent has enabled us to stay ahead of our competitors and emerging technology. We believe that the secret to our success is that we hire on character, intellect, and skill - in that order - and we are focused purely on digital. We seek digital natives who demonstrate the following characteristics: ever learning, industriousness, resilience, generosity, and extraordinary competence. It is the daily application of these core characteristics that drives our ability to innovate and create competitive advantage for our customers’ brands. I am extraordinarily grateful to be surrounded by such a committed, smart, and talented team.”

For two decades, Arteric has combined data-guided, experience-driven insight to create competitive advantage for pharmaceutical brands, biotechnology brands, and healthcare organizations. Contact Hans Kaspersetz at 201.546.9910 to advance your brand with leading-edge digital marketing solutions that work everywhere, every time.

About Arteric
Arteric is a pharmaceutical and biotechnology digital marketing agency built on a foundation of technology expertise - digital strategy, software engineering, data, search engine optimization, and search engine marketing. Arteric is the digital agency that will propel your clinical trials recruitment, pre-market shaping, disease state education, brand launch, or brand revitalization forward with digital insights and execution that cannot be matched.

Contact Information:
Arteric
Ross O'Shea
201.546.9910
Contact via Email
https://arteric.com

Read the full story here: https://www.pr.com/press-release/759636

Press Release Distributed by PR.com

Copyright PR.com


Page: 1


Related Keywords:Communications,Marketing,Online Marketing & SEO,Medical & Health,Biotechnology,Healthcare,Medical Products,Pharmaceuticals,Technology,Information
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  • CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
  • Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines